上海交大醫(yī)學院免疫學博士，十年生物學資深研究經(jīng)歷（上海中科院健康科學研究所及美國Harbor-UCLA醫(yī)學中心），從事細胞免疫和免疫排異的分子機制、內(nèi)分泌男科學、細胞增殖與凋亡的信號轉導研究，共發(fā)表了35篇科學論文。在葛蘭素史克中國研發(fā)中心八年工作期間負責多個全球創(chuàng)新項目的研發(fā)，在早期研發(fā)、臨床前研究、國際臨床研究和CRO管理方面具有的豐富經(jīng)驗。

Taylor Guo, Chief Scientific Officer, Ph.D. in Immunology from Shanghai JiaoTong University School of Medicine. Dr. Guo has a decade of discovery and early development experience in neuroimmunology, immuno-oncology and neurodegeneration at I-Mab Biopharma and GSK, with extensive experience in developing facile and robust translatable in vitro and PD assays. He published more than 35 papers.